Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected].

scientific article published in September 2005

Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected]. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.YGYNO.2005.05.003
P698PubMed publication ID15982726

P2093author name stringElizabeth A Gray
William T Creasman
Matthew Kohler
Rajesh S Mathur
Subbi P Mathur
Derrick Lane
Paul G Underwood
P2860cites workTumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesisQ24669710
VEGF-C mediates cyclic pressure-induced endothelial cell proliferationQ28208643
Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cellsQ28211849
Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors. VEGF D and flt-4t(Delta773-1081) overexpression is diagnostic for sentinel lymph node metastasisQ33202253
Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinomaQ35041319
Lymphangiogenesis and tumor metastasisQ35186253
Lymphatics at the crossroads of angiogenesis and lymphangiogenesisQ35805972
A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancerQ36646055
Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer.Q36671720
Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancersQ36695475
Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancersQ40442727
In vitro downregulation of growth factors by insulin-like growth factor binding protein-3 in cervical cancerQ40619644
Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D.Q40712610
Expression and significance of VEGF-C and FLT-4 in gastric cancer.Q42005916
Insulin-like growth factor II in gynecological cancers: a preliminary studyQ43486612
Up-regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell linesQ45280006
Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumorsQ46516597
Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinomaQ47727271
Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer.Q53615125
Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer.Q54781946
Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesisQ59607660
Cervical epidermal growth factor-receptor (EGF-R) and serum insulin-like growth factor II (IGF-II) levels are potential markers for cervical cancerQ73184364
Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancerQ73725413
Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with malignant bone tumorsQ73853983
Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgeryQ74492639
Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survivalQ77753199
Lymphangiogenesis and tumor metastasisQ79092311
Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancerQ79366823
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectcervix uterine cancerQ160105
biomarkerQ864574
P304page(s)467-483
P577publication date2005-09-01
P1433published inGynecologic OncologyQ5625182
P1476titleSerum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected].
P478volume98

Reverse relations

cites work (P2860)
Q34112190Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer
Q37156639Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?
Q53611411Clinical significance of RCAS1 as a biomarker of uterine cancer.
Q38304904Down-regulation of insulin-like growth factor binding protein-5 (IGFBP-5): novel marker for cervical carcinogenesis
Q34795458Effects of a nutrient mixture on immunohistochemical localization of cancer markers in human cervical cancer HeLa cell tumor xenografts in female nude mice
Q36612618First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours
Q84190566Lymphangiogenesis and cancer metastasis
Q34351507PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer.
Q36137715Resistive-Pulse Measurements with Nanopipettes: Detection of Vascular Endothelial Growth Factor C (VEGF-C) Using Antibody-Decorated Nanoparticles
Q37328423Serum biomarkers for early detection of gynecologic cancers
Q57788704Serum vascular endothelial growth factor-C levels predict lymph node metastasis and prognosis of patients with gallbladder cancer
Q84701414Serum vascular endothelial growth factors a, C and d in human breast tumors
Q36265146Tumor-induced VEGF-C overexpression in retroperitoneal lymph nodes in VX2 carcinoma-bearing rabbits
Q36901201VEGF-c expression in an in vivo model of orthotopic endometrial cancer and retroperitoneal lymph node metastasis
Q45212474Vascular endothelial growth factor C expression is closely correlated with lymph node recurrence and poor prognosis in patients with early stage cervical cancer
Q46119200Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism
Q39457372Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.